Information Library
Phase I/IIa
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
The New Health Clinical Brochure
August 31, 2010
Japanese version available for download. -
Biomarkers as an Approach to Improving Productivity in Oncology Drug Development
August 19, 2010
Richard Gaynor, MD of Eli Lilly presents Biomarkers as an Approach to Improving Productivity in Oncology Drug Development -
Improvements in Trial Design
August 13, 2010
Denis Lacombe, MD, MSc European Organisation for Research and Treatment of Cancer Presents Improvements in Trial Design at ASCO 2010. -
Improvements in Trial Design
August 13, 2010
Gail Eckhardt, MD University of Colorado Cancer Center presents Improvements in Trial Design -
A Focus on CNS
July 28, 2010
Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. -
Malaysia Prime Site
July 2, 2010
Adam Chasse, Sr. Director, Access to Patients explains the importance of Prime Sites and the impact of our clinical research partnership with the University of Malaya Medical Centre in Malaysia. -
Deciding Factors
June 30, 2010
PK-PD modeling and simulation scientists from Quintiles rescued the sponsor's TQT protocol by determining key inputs needed to satisfy FDA guidelines. -
Targeting Oncology
June 2, 2010
Learn more about Quintiles leadership in oncology product development and commercialization. -
Applications of Modeling and Simulation
May 27, 2010
Applications of Modeling and Simulation is discussed by Giridhar S. Tirucherai PhD, Director, Clinical PK-PD at Quintiles in the April issue of DIA Global Forum. -
Assessing Cardiac Safety Throughout Clinical Development
May 27, 2010
Assessing Cardiac Safety Throughout Clinical Development and the ramifications for an integrated cardiac safety program is discussed by Rick Turner, Senior Scientific Director at Quintiles in the April issue of DIA Global Forum.